Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Learn about the credit cards that offer the highest cash back rates. Make informed choices to maximize your rewards and savings.
25,960 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A tiny stock with a big frontier, D-Wave has captured headlines as its shares rally. This article breaks down what ha...
A notable fund just built a fresh position in a cloud security leader. Discover the numbers behind winmill loads qual...
In 2026, retirees confront six-figure required minimum distributions even after a broad tax bill. Analysts say the co...
A high-profile insider move shines a light on AI-driven demand for Willdan's engineering services. This piece breaks ...
As rate dynamics shift in 2026, investors weigh a dividend portfolio that starts with a strong yield but relies on gr...
Finance Of America has closed an all-cash acquisition of Onity’s reverse mortgage servicing rights, adding roughly 20...
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Adobe posted solid quarterly results but faces mounting downgrades as analysts question AI monetization, pricing powe...
Is Pinterest a fleeting trend or a long-term opportunity? This article weighs the case for a pinterest stock generati...